CRISPR leg­end Jen­nifer Doud­na helps some re­cent col­lege grads launch a di­ag­nos­tics up­start

A group of re­cent and cur­rent grad stu­dents in the Bay Area have come to­geth­er to launch a new com­pa­ny that promis­es to use CRISPR tech­nol­o­gy to cre­ate a line­up of di­ag­nos­tic tests that may one day make di­ag­nos­ing can­cer or malar­ia or most any­thing a snap.

And aside from the tech they’ve in-li­censed out of Berke­ley, the young en­tre­pre­neurs have one big as­set in their fa­vor. Jen­nifer Doud­na, one of the most fa­mous sci­en­tif­ic pi­o­neers be­hind CRISPR/Cas9 gene edit­ing tech, is com­ing on board as a co-founder.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER